Cargando…
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
Epithelial-to-mesenchymal transition (EMT) is a hallmark of aggressive, mesenchymal-like high-grade serous ovarian carcinoma (HGSOC). The SRC kinase is a key driver of cancer-associated EMT promoting adherens junction (AJ) disassembly by phosphorylation-driven internalization and degradation of AJ p...
Autores principales: | Bley, Nadine, Schott, Annekatrin, Müller, Simon, Misiak, Danny, Lederer, Marcell, Fuchs, Tommy, Aßmann, Chris, Glaß, Markus, Ihling, Christian, Sinz, Andrea, Pazaitis, Nikolaos, Wickenhauser, Claudia, Vetter, Martina, Ungurs, Olga, Strauss, Hans-Georg, Thomssen, Christoph, Hüttelmaier, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951963/ https://www.ncbi.nlm.nih.gov/pubmed/32876513 http://dx.doi.org/10.1080/15476286.2020.1812894 |
Ejemplares similares
-
The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family
por: Busch, Bianca, et al.
Publicado: (2016) -
IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors
por: Müller, Simon, et al.
Publicado: (2018) -
IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
por: Zirkel, Anne, et al.
Publicado: (2013) -
Oncogenic Potential of the Dual-Function Protein MEX3A
por: Lederer, Marcell, et al.
Publicado: (2021) -
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
por: Hagemann, Sven, et al.
Publicado: (2023)